complementary sequences in the 3′-untranslated region (UTR) of target mRNAs (Lin & Gregory, 2015) . More than 2,500 human miRNAs have been reported to date and over 30% of the human genes are predicted to be regulated by these miRNAs. Increasing evidence suggests that miRNAs are aberrantly expressed in multiple human tumors and involved in critical oncogenesis processes such as cell proliferation, differentiation, migration, and invasion (Lai et al., 2018) . Dysregulation of miRNAs has been reported to be strongly associated with the progression and prognosis of OSCC (Tu, Lin, & Chang, 2013) . In particular, a number of miRNAs, for example, miR-22, miR-124, miR-433, and miR-375 (Feng, Luo, Wang, Zhang, & Chen, 2018; Hunt, Jones, Hinsley, Whawell, & Lambert, 2011; Wang et al., 2017; Zhang et al., 2017) , have been reported to inhibit OSCC cell growth, migration, and apoptosis, and have been recognized as novel targets in OSCC diagnosis and therapy.
In a recent study, microRNA-16 (miR-16) was identified to be downregulated in OSCC tissues (Manikandan et al., 2016) . miR-16 is a novel cancer-associated miRNA and has been recognized as a tumor suppressor in different types of human cancers, including breast cancer (Guo, Connick, Vanderhoof, Ishak, & Hartley, 2015) , colorectal cancer (Ma et al., 2013) , bladder cancer (Jiang, Liu, & Yuan, 2013) , gastric adenocarcinoma (Kang et al., 2015) , and hepatocellular carcinoma (Wu, Wang, Yao, & Li, 2015) . However, the role of miR-16 in OSCC and the underlying molecular mechanism remain to be delineated.
In the current study, we aimed to investigate the expression level of miR-16 in OSCC tissues and cell lines and assess the effect of miR-16 on cell proliferation and apoptosis. Moreover, the mechanisms underlying the role of miR-16 together with its target genes in OSCC progression were also explored in OSCC cells and animal models. 
| MATERIALS AND METHODS

| Ethics statement
| Cell culture and transfection
Human immortalized oral epithelial cells (HIOEC) and five human OSCC cell lines (SCC-4, SCC-25, HN-6, CAL-27, and TCA-83) were purchased from the Type Culture Collection of the Chinese Academy of Science (Shanghai, China). Cells were maintained in Dulbecco modified Eagle's medium (Gibco, Invitrogen Corporation, Carlsbad, CA) with 10% fetal bovine serum (Gibco) and 1% penicillin/streptomycin at 37℃ in a standard humidified incubator containing 5% CO 2 .
The miR-16 mimic, the miR-16 inhibitor, and their corresponding negative control (miR-16 mimic NC and miR-16 inhibitor NC) were purchased from RiboBio Co., Ltd. (Guangzhou, China). SCC-25 and CAL-27 cells were transfected with the above mimic/inhibitor or corresponding negative control for 48 hr using Lipofectamine 2000 (Life Technologies, Waltham, MA) according to the manufacturer's protocol.
For the overexpression of AKT3 and BCL2L2, the cDNA of AKT3 or BCL2L2 was cloned into the mammalian expression vector pcDNA3.1 (Invitrogen, Waltham, MA), respectively, to construct two overexpressed vectors; pcDNA3.1-AKT3 and pcDNA3.1-BCL2L2. The pcDNA3.1 was used as a NC. 
| Cell proliferation and apoptosis assay
| Animal experiments
A total of forty 6-week-old male BALB/c nude mice (20-25 g) were purchased from Beijing HFK Bioscience Co., Ltd (Beijing, China) and were fed in the specific pathogen-free laboratory at room Mice were killed on the 27th day after inoculation, and the tumor was then surgically removed and weighed. Tumor tissues were immediately placed in liquid nitrogen for RNA and protein extraction.
| Statistical analysis
All data were presented as means ± standard deviation and analyzed with Prism 6 (GraphPad Software, CA). Student t test was used to determine the significance between two independent groups. Oneway analysis of variance, followed by Dunnett's test were used to conduct the multiple comparisons. Pearson correlation analysis was used to determine the correlations between miR-16 and AKT3 or BCL2L2 expression. p < 0.05 was considered statistically significant.
| RESULTS
| miR-16 is downregulated in OSCC tissues and cell lines
The Compared with the NC group, the miR-16 mimic suppressed the cell viability of SCC-25 and CAL-27 cells. Additionally, it was found that the miR-16 inhibitor significantly promoted cell viability (Figure 2b,d) . Furthermore, an Annexin V/PI staining analysis was performed to investigate the function of miR-16 in cell apoptosis.
We found that the apoptotic rate was significantly increased in miR-16 mimic transfected cells; conversely, the apoptotic rate was decreased after the expression of miR-16 was inhibited in SCC-25 and CAL-27 cells ( Figure 3 ). All these results indicated that miR-16 could reduce proliferation and induce apoptosis in OSCC cells.
3.3 | miR-16 directly targets the 3′-UTR of AKT3 and BCL2L2
To elucidate the molecular mechanisms by which miR-16 exerts its functional effects on OSCC cells, TargetScan 
| Overexpression of AKT3 and BCL2L2 promotes proliferation and inhibits apoptosis in OSCC cells
To further investigate whether the regulatory action of miR-16 on cell proliferation and apoptosis was mediated by its target genes AKT3 and BCL2L2, overexpression vectors of AKT3 and BCL2L2
were constructed and cotransfected with miR-16 into SCC-25
cells. Western blot analysis demonstrated that the protein expression of AKT3 downregulated by the miR-16 mimic was restored after pcDNA3.1-AKT3 transfection (Figure 6a ). Furthermore, the restoration of AKT3 could partly overcome the inhibitory effects of miR-16 on cell proliferation (Figure 6b ).
Moreover, overexpression of AKT3 also significantly inhibited the apoptosis of SCC-25 cells induced by miR-16 (Figure 6c,d) .
Similarly, the expression of BCL2L2 was upregulated after pcDNA3.1-BCL2L2 transfection, which also partly reversed the regulatory action of miR-16 on cell proliferation and apoptosis (Figure 7 ).
| miR-16 inhibits SSC-25 engrafted tumor growth in vivo
To Previous studies showed that overexpression of miR-16 declined cellular proliferation and induced apoptosis in hepatocellular carcinoma and breast cancer cells (Mobarra et al., 2015; Wu et al., 2015) . We therefore examined the function of miR-16 in cell proliferation and apoptosis in SCC-25 and CAL-27 cell lines by the miR-16 mimic and inhibitor. Results indicated that miR-16 overexpression led to inhibition of cell proliferation and induction of apoptosis, whereas miR-16 knockdown induced promotion of cell proliferation and suppression of apoptosis. These data indicate that miR-16 plays a tumor-suppressive role in OSCC.
We further searched the potential target gene of miR-16 using a bioinformatics tool and found that AKT3 and BCL2L2 are downstream target mRNAs. AKT3 is a homologous gene that belongs to the serine/ threonine protein kinase AKT subfamily. Once AKT3 has been hyperactivated in tumorigenesis, it could be a vulnerable node to be targeted (Zboray, Mohrherr, Stiedl, Pranz, & Wandruszka, 2017) . The expression and activation of AKT3 mediates cancer progression and controls cellular processes such as cell growth, proliferation, apoptosis, and invasion (Kim et al., 2016) . As an oncogene, AKT3 was found to be upregulated in many types of cancers by enhancing the activity of cancer cells (Madhunapantula & Robertson, 2017; Mure et al., 2010; Shao & Aplin, 2010) , whereas knockdown of AKT3 isoforms has been reported to abrogate the growth of tumors through inducing cell apoptosis and inhibiting proliferation (Paul-Samojedny et al., 2014 , 2015 . Moreover, emerging evidence suggests that AKT3 was regulated by a series of miRNAs, such as miR-29b , miR-582 (Jin et al., 2017) , miR-497 , and miR-338 (Sui et al., 2017) , which could suppress cancer progression. In line with these findings, AKT3 was also identified as a target gene of miR-16 in this study. Luciferase activity BCL2L2, a prosurvival member of the BCL2 protein family, has been reported to function as an oncogene in reducing apoptosis and promoting cell survival (Qu et al., 2015) . The activation of BCL2L2 is closely related to the occurrence and progression of tumors. It was reported that BCL2L2 was upregulated in diverse human malignancies (Lu et al., 2016; Wang, Liu, Li, & Tang, 2013) . We proved that miR-16 downregulated the mRNA and protein expressions of BCL2L2 through directly binding the 3′-UTR site. The inverse correlation between miR-16 and BCL2L2 levels in OSCC tissues supported this conclusion. In addition, we verified that over expression of BCL2L2 counteracted the effects of miR-16 on cell Together, our data provide evidence that miR-16 may inhibit proliferation and induce apoptotic signals at least in part through reducing the expression of AKT3 and BCL2L2.
In addition to AKT3 and BCL2L2, some other genes were also identified as the potential downstream targets of miR-16, such as YAP1 and Cyclin E1. These genes were reported to be related to diverse cancers. For example, a previous study indicated that YAP1 saved an oncogenic function in gastric adenocarcinoma development, and elevated cyclin E1 is associated with breast cancer and present throughout the cancer cell cycle (Guo et al., 2015; Kang et al., 2015) . The functions and mechanisms of these genes regulated by miR-16 in OSCC still need to be explored in further studies. Besides, the limitation in this study is that the sample size was small; there were only eighteen OSCC patients. Although this does not affect the results, the expression of miR-16 would be further verified in a larger cohort of OSCC patients.
In summary, this study revealed that miR-16 was downregulated in OSCC tissues and cell lines, and it inhibited cell proliferation and induced apoptosis through decreasing the downstream genes AKT3
and BCL2L2. To our knowledge, this report is the first to suggest that miR-16 acts as a tumor-suppressor miRNA in OSCC by directly targeting AKT3 and BCL2L2. The findings will improve our understanding of the mechanisms involved in cancer progression and provide novel targets for the molecular treatment of OSCC.
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